Sort
51,570 grants matching “autoimmune disease”
Mechanisms for peripheral induction of T cell tolerance
$741,294University Of Minnesota Twin Cities · P01 · FY2003 · AI
Interrogating unique DC adaptations to tissue to promote barrier immunity and tolerance
$741,228Niroshana Anandasabapathy · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AR
Development of An Automated High-Throughput Dried Blood Spot Assay to Facilitate Large Scale Screening for Type 1 Diabetes Risk
$741,180David Seftel · Enable Biosciences, Inc. · R44 · FY2020 · DK
Personalized precision dosing of anti-TNF biologic therapies
$741,072Bradley T Messmer · Abreos Biosciences, Inc. · R44 · FY2019 · AI
Autoantibodies define scleroderma subgroups with distinct relationships to cancer
$741,025Ami Aalok Shah · Johns Hopkins University · R01 · FY2024 · AR
Protein Modifications Involved in Cell Signaling
$741,012Aleksandra Nita-Lazar · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
The Impact of Tolerance in the Newborn on Lentiviral Infection
$740,981Joseph M McCune · University Of California, San Francisco · R01 · FY2012 · AI
Serum miRNA Biomarkers of Islet Autoimmunity
$740,959Alberto Pugliese · University Of Miami School Of Medicine · R01 · FY2019 · AI
A Systems Biology Approach to Malaria Immunity
$740,904Kim C Williamson · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2016 · AI
A dual-acting small molecule for the treatment of type 1 diabetes
$740,897Shiyong Wu · Asake Biotechnology, Llc · R42 · FY2024 · DK
Tissue-Anchored vs. Circulating Engineered Enzyme Constructs for Immunometabolic Resolution of Psoriasis
$740,837Benjamin George Keselowsky · University Of Florida · R01 · FY2025 · AI
Leveraging Human iPSC-derived beta-cells to Probe Antigen Specificity of Anti-islet Memory T Cells in T1D
$740,696Luc Teyton · Scripps Research Institute, The · R01 · FY2024 · DK
Health Effects Of Exposures In Agriculture
$740,470Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES
New radiotracer development to study immune cell mobilization of granzyme proteolytic activity
$740,394Michael John Evans · University Of California, San Francisco · R01 · FY2022 · AI
The role of protease activated receptor 2 in the initiation and progression of abdominal aortic aneurysm
$740,338Albert Phillip Owens III · University Of Cincinnati · R01 · FY2025 · HL
Salivary Biomarkers for Sjogren's Syndrome Detection-Definitive Validation
$740,177David T Wong · University Of California Los Angeles · U01 · FY2012 · DE
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes
$740,135Wei-Jun Qian · Battelle Pacific Northwest Laboratories · R01 · FY2021 · DK
Gene Regulation In The Immune System
$740,049Keiko Ozato · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2016 · HD
Delivery of Biological Therapeutics: Using Engineered Particles and Novel Deliver
$740,000Joseph M Desimone · Univ Of North Carolina Chapel Hill · DP1 · FY2010 · OD
Delivery of Biological Therapeutics: Using Engineered Particles and Novel Deliver
$740,000Joseph M Desimone · Univ Of North Carolina Chapel Hill · DP1 · FY2009 · OD
Regulation of human dendritic cell activation
$739,908Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Effects of the Next Generation TNF Inhibitor (XPro1595) on Inflammation-related Deficits in Reward Circuitry and Motivation in Depression
$739,739Christopher J Barnum · Inmune Bio, Inc. · R44 · FY2020 · MH
Development of linkage-specific ubiquitin binding elements
$739,313James Strickler · Lifesensors, Inc. · R44 · FY2015 · CA
Humoral And Cellular Tolerization Approaches Against Au*
$739,244Massimo M. Trucco · Children'S Hosp Pittsburgh/Upmc Hlth Sys · U19 · FY2006 · AI
PTPN22 R619W in NOD mice
$739,100Linda A Sherman · Scripps Research Institute, The · R56 · FY2016 · AI